Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE).
Saved in:
| Title: | Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). |
|---|---|
| Authors: | Rousseau, Caroline1,2 (AUTHOR) Caroline.Rousseau@ico.unicancer.fr, Heyman, M. F.1,3 (AUTHOR), Ferrer, L.1 (AUTHOR), Rauscher, A.1 (AUTHOR), Morel, A.1 (AUTHOR), Rusu, D.1 (AUTHOR), Frenel, JS1,2 (AUTHOR), Taupin, M.4 (AUTHOR), Vilcot, L.1 (AUTHOR), Allam, N.1 (AUTHOR), Robert, M.1,2 (AUTHOR), Campone, M.1,2 (AUTHOR), Campion, L.1,2 (AUTHOR), Kraeber-Bodéré, F.5 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Mar2026, Vol. 53 Issue 4, p2403-2413. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-025-07619-y |
